These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1191 related items for PubMed ID: 28640470

  • 21. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program.
    Vogel I, Petersen OB, Christensen R, Hyett J, Lou S, Vestergaard EM.
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):480-486. PubMed ID: 28608362
    [Abstract] [Full Text] [Related]

  • 22. The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.
    Hartwig TS, Sørensen S, Jørgensen FS.
    Prenat Diagn; 2016 Jul; 36(7):643-9. PubMed ID: 27135649
    [Abstract] [Full Text] [Related]

  • 23. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK, Cheung SW, Smith JL, Bi W, Ward PA, Peacock S, Braxton A, Van Den Veyver IB, Breman AM.
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [Abstract] [Full Text] [Related]

  • 24. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y, Wang R, Xi M, Wei L, Zhu W, Liu Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug 10; 40(8):933-938. PubMed ID: 37532491
    [Abstract] [Full Text] [Related]

  • 25. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R, Sarno L, Ispas A, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Jun 10; 47(6):698-704. PubMed ID: 26743020
    [Abstract] [Full Text] [Related]

  • 26. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U, Chaubey A, Shenoy S, Wong YW, Chan LY, Choo BP, Oraha L, Gousseva A, Persson F, Prensky L, Chin E, Hegde M.
    Curr Issues Mol Biol; 2021 Aug 17; 43(2):958-964. PubMed ID: 34449543
    [Abstract] [Full Text] [Related]

  • 27. Decoding 22q11.2: prenatal profiling and first-trimester risk assessment in Danish nationwide cohort.
    Gadsbøll K, Vogel I, Pedersen LH, Kristensen SE, Steffensen EH, Wright A, Wright D, Hyett J, Petersen OB, Danish Cytogenetic Central Registry study group.
    Ultrasound Obstet Gynecol; 2024 Jan 17; 63(1):34-43. PubMed ID: 37643358
    [Abstract] [Full Text] [Related]

  • 28. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M, De Falco L, Torella A, Savarese G, Savarese P, Ruggiero R, Conte A, Fico V, Torella M, Fico A.
    BMC Med Genomics; 2021 Mar 30; 14(1):93. PubMed ID: 33785045
    [Abstract] [Full Text] [Related]

  • 29. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM.
    Ultrasound Obstet Gynecol; 2013 Jul 30; 42(1):41-50. PubMed ID: 23744626
    [Abstract] [Full Text] [Related]

  • 30. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ, Alfirevic Z, Audibert F, Kagan KO, Paladini D, Yeo G, Raine-Fenning N, ISUOG Clinical Standards Committee.
    Ultrasound Obstet Gynecol; 2017 Jun 30; 49(6):815-816. PubMed ID: 28573775
    [No Abstract] [Full Text] [Related]

  • 31. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2017 Sep 30; 50(3):302-314. PubMed ID: 28397325
    [Abstract] [Full Text] [Related]

  • 32. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A, Palma-Dias R, da Silva Costa F, Meagher S, Nisbet DL, Scott F.
    Aust N Z J Obstet Gynaecol; 2016 Feb 30; 56(1):22-8. PubMed ID: 26817523
    [Abstract] [Full Text] [Related]

  • 33. Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis.
    Torres Aguilar MR, Carrasco Salas P, Santos Rosa C, Bueno Rodríguez G, Martínez-Bonet E, Carreto Alba P, León-Justel A, Granell Escobar MR.
    Taiwan J Obstet Gynecol; 2021 Jul 30; 60(4):745-751. PubMed ID: 34247818
    [Abstract] [Full Text] [Related]

  • 34. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH, Syngelaki A, Poon LC, Gil MM, Wright D.
    Fetal Diagn Ther; 2014 Jul 30; 35(3):185-92. PubMed ID: 24192489
    [Abstract] [Full Text] [Related]

  • 35. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Jun 30; 31(6):618-24. PubMed ID: 18461550
    [Abstract] [Full Text] [Related]

  • 36. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K, Nicolaides KH.
    BJOG; 2003 Mar 30; 110(3):276-80. PubMed ID: 12628267
    [Abstract] [Full Text] [Related]

  • 37. A cost-effectiveness analysis comparing two different strategies in advanced maternal age: Combined first-trimester screening and maternal blood cell-free DNA testing.
    Pan M, Huang LY, Zhen L, Li DZ.
    Taiwan J Obstet Gynecol; 2018 Aug 30; 57(4):536-540. PubMed ID: 30122574
    [Abstract] [Full Text] [Related]

  • 38. Parental Decisions about Prenatal Screening and Diagnosis among Infants with Trisomy 21 in a National Cohort with High Uptake of Combined First-Trimester Screening.
    Miltoft CB, Wulff CB, Kjærgaard S, Ekelund CK, Tabor A, Danish Fetal Medicine Study Group.
    Fetal Diagn Ther; 2017 Aug 30; 41(3):209-214. PubMed ID: 27455074
    [Abstract] [Full Text] [Related]

  • 39. Prenatal reflex DNA screening for trisomies 21, 18, and 13.
    Wald NJ, Huttly WJ, Bestwick JP, Old R, Morris JK, Cheng R, Aquilina J, Peregrine E, Roberts D, Alfirevic Z.
    Genet Med; 2018 Aug 30; 20(8):825-830. PubMed ID: 29120460
    [Abstract] [Full Text] [Related]

  • 40. Screening for trisomies 21 and 18 in a Spanish public hospital: from the combined test to the cell-free DNA test.
    Gil MM, Brik M, Casanova C, Martin-Alonso R, Verdejo M, Ramírez E, Santacruz B.
    J Matern Fetal Neonatal Med; 2017 Oct 30; 30(20):2476-2482. PubMed ID: 27806655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.